Health Boards
Ever wondered how many people like you there are around the world living with psoriasis? well this report suggests the figure will be well over 40 Million by 2022.
It makes interesting reading, and it was first released in 2013 for use by businesses shaping and driving the global psoriasis market.
Source: globaldata.com
It makes interesting reading, and it was first released in 2013 for use by businesses shaping and driving the global psoriasis market.
Quote:
Psoriasis has a complex collection of risk factors, such as genetics, lifestyle choices, and exposure to certain environmental conditions, states a new report from research and consulting firm GlobalData.
According to the report, there were approximately 36.5 million prevalent cases of psoriasis across all the US, France, Germany, Italy, Spain, UK, Japan, China, and India in 2012. By 2022, GlobalData epidemiologists forecast that this figure will reach approximately 40.93 million prevalent cases, following a 12.1% increase based on projected population growth - prevalence proportions are expected to remain constant.
Psoriasis is an immune-mediated chronic dermatological disorder characterized by redness and irritation. The condition affects individuals of both sexes and all ethnicities and ages, although there is a higher prevalence of psoriasis in the colder, northern regions of the world.
The age-standardized prevalence of psoriasis varies among different countries, from as low as 0.03% in Japan to as high as 1.84% in Germany. These regional differences may be attributable to variations in environmental factors such as the weather, as well as genetic factors, and differences in data collection across different countries.
The prevalence of psoriasis in the central region of Italy is 2.8 times greater than the prevalence in southern Italy, and similar regional differences have been reported in Spain, with psoriasis more common among the residents of central Spain, who experience colder and drier weather than individuals in the northern and southern regions.
Ethnicity may also play a part - studies have shown that Caucasians have a higher prevalence of psoriasis compared with African-Americans, but African-Americans in the US tend to suffer from a more severe form of the disease.
Psoriasis is an autoimmune disorder, so family history plays an important role in the development of the disease. Approximately 40% of psoriasis patients have first-degree relatives with the disease. Since psoriasis is categorized as an immune-mediated inflammatory disorder (IMFD), sufferers are also at an increased risk of developing other, more severe IMFDs, such as rheumatoid arthritis and Crohn’s disease. Psoriasis patients are also at risk of developing psoriatic arthritis, which is a progressive, deforming, and debilitating disease and the most common comorbidity associated with psoriasis.
However, lifestyle choices, and certain diseases and medications can affect the condition. Smoking increases the risk of developing psoriasis, and increases the severity of the disease. In addition, it has been noted that psoriasis is a common disease among obese patients, although the relationship between the two disorders remains unclear. Obesity also predisposes individuals to inverse or flexural psoriasis, which occurs in the folds of the skin. Various medications, such as lithium, anti-malarial agents, beta-blocking agents, and non-steroidal anti-inflammatory drugs (NSAIDs), are also considered as possible risk factors, though there is insubstantial evidence to prove this as yet.
The disease can be controlled with medication, but a cure has not yet been found. Psoriasis is often associated with unsightly lesions, scales, and inflammation, which can affect an individual’s self-esteem, leading nearly half of all psoriasis patients to report elevated stress levels, depression, and thoughts of suicide. Stress can trigger pathological processes, exacerbating many dermatological conditions, particularly psoriasis. Psoriasis patients suffering from these anxieties can also limit their social interactions and abuse alcohol and tobacco, further worsening their condition.
Source: globaldata.com
